hVSIG4
品系全名
C57BL/6JSmo-Vsig4tm1(hVSIG4)/Smoc
目录号
NM-HU-210004
品系状态
胚胎冻存
基因信息
基因名
Vsig4
品系描述
验证数据
Fig1. Analysis of human VSIG4 expression on the peritoneal exudate macrophages by FACS.
The homozygous KI mouse expresses human VSIG4 on the peritoneal exudate macrophages.
Fig.2 In vivo efficacy assessment of anti-hVSIG4 in HO hVSIG4 mice bearing MC38 syngeneic tumor.
Body weight were measured twice a week of hVSIG4 mice (n=4 , 3 male and 1 female). (A) Body weight. (B) Body weight change.
Fig.3 In vivo efficacy assessment of anti-hVSIG4 in HO hVSIG4 mice bearing MC38 syngeneic tumor.
Tumor volume were measured twice a week of hVSIG4 mice. MC38 (1×106) were inoculated subcutaneously into hVSIG4 mice (6-8-week-old, n=4, 3 male and 1 female). (A) Tumor volume. (B) Relative tumor volume.
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
